Abstract:Abstract Background: As the most popular beverage in East Asia, green tea (GT) has various biological activities effects such as anti-mutation, anti-oxidation, and anti-tumor. In this study, we aimed to evaluate whether GT consumption could be an effective way to decrease the risk of breast cancer. Methods: We had performed a systematic review and updated meta-analysis of published case–control studies to evaluate the association between GT intake and the risk of breast cancer. Searching strategies were performed by the following keywords “Breast cancer,” “breast neoplasm,” and “green tea,” with derivations and different combinations. The following databases were searched: PubMed, Cochrane Library, EMBASE, Web of science, China National Knowledge Infrastructure, WanFang, and China Biology Medicine disc. Studies published in both English and Chinese were considered for inclusion. Risk of bias was assessed through the Newcastle-Ottawa Scale (NOS). All data were analyzed through using Review Manager 5.1 software. Results: Fourteen studies fulfilled inclusion criteria for meta-analysis, yielding a total of 14,058 breast cancer patients and 15,043 control subjects. Individuals with the habit of drinking GT were found to have a negative association with the risk of future breast cancer (odds ratio 0.83; 95% confidence interval: 0.72–0.96) despite significant heterogeneity. In subgroup analyses, the negative correlation was still found in studies using registry-based controls, NOS grades ≥6 and the number of cases <500. Conclusions: GT consumption may have a decreased incidence of breast cancer despite significant heterogeneity. However, owing to the quality of available studies, more properly designed trials are warranted to clarify the association between GT consumption and breast cancer.

Effect of Green Tea on VEGF Expression and Its Mechanism in Human Breast Cancer Cells

Inhibition Effect of Green Tea on Bfgf Expression in Cultured Human Breast Cancer Cells and Endothelial Cells

Green Tea Inhibits Vascular Endothelial Growth Factor (Vegf) Induction In Human Breast Cancer Cells

The Effect of Tea Polyphenols on the Production of ROS and TGF-β1 by Endothelial Cells in High Glucose Culture Media

Inhibitory Effects of Tea and Tea Catechins on Breast Cancer

Green tea and its anti-angiogenesis effects

Green Tea Catechin, Epigallocatechin-3-Gallate, Inhibits Vascular Endothelial Growth Factor Angiogenic Signaling By Disrupting The Formation Of A Receptor Complex

Green tea and the prevention of breast cancer: a case-control study in Southeast China.

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Suppression of Wnt Signaling by the Green Tea Compound (–)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells

Suppressive Effects of Tea Catechins on Breast Cancer

Inhibition of green tea polyphenol on angiogenesis of chick chorioallantoic membrance

Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.

Green Tea Consumption and Risk of Breast Cancer

Effects of Green Tea on Blood Pressure and Hypertension-Induced Cardiovascular Damage in Spontaneously Hypertensive Rat

Effect of Green Tea Catechins on Vascular Cell Proliferation and Reactive Oxygen Species

Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2

Inhibitory Effect of EGCG on Proliferation and HIF-1α/VEGF Expression in Cell Line HepG2

Bioinformatic Prediction of Possible Targets and Mechanisms of Action of the Green Tea Compound Epigallocatechin-3-Gallate Against Breast Cancer